Bríd O’Flaherty

Bríd O’Flaherty is a barrister appointed as the chairwoman of the inquiry into the historical licensing and use of the anti-epileptic drug sodium valproate in Ireland, a role that involves leading investigations into the drug's impact on women of childbearing age and the potential risks to their children.